GENE ONLINE|News &
Opinion
Blog

Genome Editing
Groundbreaking CRISPR/Cas9-based Genome Editing Therapy Secured the Second FDA Approval
2024-01-18
Re-engineered Bacterial “Syringes” for Programmable Protein Delivery
2023-04-06
Massive Human CRISPR-Based Genotype-Phenotype Map Is Now Complete
2022-06-13
EdiGene Digs Into Cell Therapies with Arbor and Neukio Partnerships
2022-02-10
Emerging Gene Editing Technologies and Applications
2021-05-19
Mammoth Biosciences Signs Deal with UC Berkeley for Novel Micro CRISPR Protein
2020-08-16
Peeking into the Future of Synthetic Biology and Gene Editing, an Exclusive Interview with Dr. George Church
2020-02-13
CRISPR Scientists Seek a Moratorium on Heritable Genome Editing
2019-03-15
LATEST
Lotus Pharma Expands in Southeast Asia with Alpha Choay Acquisition from Sanofi
2024-09-06
Indian CDMO Stocks in the Spotlight: US House to Vote on BIOSECURE Act Next Week
2024-09-06
Eli Lilly Joins Forces with AI Startup Genetic Leap in $409M Deal Centered Around RNA-Targeted Drug Discovery
2024-09-06
Illumina Wins EU Court Battle, Dodges Fine, but Grail Deal Already Void
2024-09-05
Breaking New Ground for Clinical Trials with AI/ML Applications
2024-09-05
InMed Pharmaceuticals’ Positive Market Response to Cannabinoid Analog INM-901 for Alzheimer’s Treatment
2024-09-04
Alnylam Pharma Shares Dip Despite Positive Phase 3 HELIOS-B Heart Disease Results
2024-09-04
EVENT
2024-09-11
2024 Bio Asia Pacific
Bangkok, Thailand
2024-09-13
ESMO Congress 2024
Barcelona, Spain
2024-10-09
Medical Japan 2024 Tokyo
Tokyo, Japan
2024-10-15
BIO Investor Forum 2024
San Francisco, U.S.A.
Scroll to Top